Respiratory pathogens and acute chest syndrome in children with sickle cell disease

Marie-Caroline Ploton1,2, Julie Sommet3, Bérengère Koehl4

  • 1Department of General Pediatrics and infectious diseases, Hôpital Universitaire Robert-Debré, Paris, France.

Insights

In children with sickle cell disease (SCD), viral respiratory infections are common but not linked to acute chest syndrome (ACS). This study found no association between viral pathogens and ACS in pediatric SCD patients.

Area of Science:

  • Pediatric Hematology
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Acute chest syndrome (ACS) is a complication in children with sickle cell disease (SCD).
  • The epidemiology of viral and intracellular respiratory pathogens causing fever and/or ACS in pediatric SCD patients is not well-established.
  • Understanding these pathogens is crucial for managing SCD complications.

Purpose of the Study:

  • To determine the epidemiology of viral and intracellular respiratory pathogens in children with SCD presenting with fever and/or ACS.
  • To investigate the association between specific respiratory pathogens and the occurrence of ACS in this population.

Main Methods:

  • An observational, prospective, single-center cohort study.
  • 101 children with SCD admitted for fever and/or ACS were screened for 20 respiratory pathogens using multiplex PCR (FilmArray).
  • A nested case-control analysis compared children with ACS to those without.

Main Results:

  • At least one pathogen was detected in 67% of children.
  • The most common viruses were rhinovirus (33), adenovirus (14), RSV (13), and parainfluenza (11).
  • No statistical association was found between viral detection and ACS (p=0.51), although parainfluenza viruses were more frequent in ACS cases.

Conclusions:

  • Viral detection is frequent in febrile children with SCD, but a direct association with ACS was not demonstrated in this study.
  • Mycoplasma pneumoniae was infrequently detected in young children with SCD experiencing ACS.
  • Further research may be needed to elucidate the specific triggers of ACS in pediatric SCD patients.
Abstract

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.8K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.4K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
662
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
643
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
917
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
374